MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies

International Journal of Cancer

Volumn 129, Issue 5, 2011, Pages 1137-1148

  Schultz Thater, Elke ^a   Piscuoglio, Salvatore ^a   Iezzi, Giandomenica ^a   Le Magnen, Clémentine ^a   Zajac, Paul ^a   Carafa, Vincenza ^a   Terracciano, Luigi ^a   Tornillo, Luigi ^a   Spagnoli, Giulio C ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

cancer immunotherapy; cancer testis tumor associated antigens; immunohistochemistry; MAGE A10; tissue microarray

Indexed keywords

EPITOPE; GENE PRODUCT; MELANOMA ANTIGEN 10; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MELANOMA; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; SKIN CANCER; TISSUE DISTRIBUTION; TISSUE MICROARRAY; TUMOR CELL; UROGENITAL TRACT CANCER;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED; UROLOGIC NEOPLASMS;

EID: 79959750876     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25777     Document Type: Article

References (50)

1. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT,. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002; 188: 22-32. (Pubitemid 35398862)
2. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ,. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005; 5: 615-25. (Pubitemid 41081387)
3. Juretic A, Spagnoli GC, Schultz-Thater E, Sarcevic B,. Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies. Lancet Oncol 2003; 4: 104-9. (Pubitemid 36193170)
4. Bricard G, Bouzourene H, Martinet O, Rimoldi D, Halkic N, Gillet M, Chaubert P, Macdonald HR, Romero P, Cerottini JC, Speiser DE,. Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma. J Immunol 2005; 174: 1709-16.
5. Groeper C, Gambazzi F, Zajac P, Bubendorf L, Adamina M, Rosenthal R, Zerkowski HR, Heberer M, Spagnoli GC,. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Int J Cancer 2007; 120: 337-43. (Pubitemid 44956843)
6. Le Gal FA, Widmer VM, Dutoit V, Rubio-Godoy V, Schrenzel J, Walker PR, Romero PJ, Valmori D, Speiser DE, Dietrich PY,. Tissue homing and persistence of defined antigen-specific CD8+ tumor-reactive T-cell clones in long-term melanoma survivors. J Invest Dermatol 2007; 127: 622-9.
7. Sartorius R, Pisu P, D'Apice L, Pizzella L, Romano C, Cortese G, Giorgini A, Santoni A, Velotti F, De BP,. The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses. J Immunol 2008; 180: 3719-28.
8. Valmori D, Dutoit V, Rubio-Godoy V, Chambaz C, Lienard D, Guillaume P, Romero P, Cerottini JC, Rimoldi D,. Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma. Cancer Res 2001; 61: 509-12. (Pubitemid 32128608)
9. Carrel S, Schreyer M, Spagnoli G, Cerottini JC, Rimoldi D,. Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells. Int J Cancer 1996; 67: 417-22. (Pubitemid 26274135)
10. Gervois N, Guilloux Y, Diez E, Jotereau F,. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions. J Exp Med 1996; 183: 2403-7. (Pubitemid 26158935)
11. Rimoldi D, Salvi S, Reed D, Coulie P, Jongeneel VC, De Plaen E, Brasseur F, Rodriguez AM, Boon T, Cerottini JC,. cDNA and protein characterization of human MAGE-10. Int J Cancer 1999; 82: 901-7. (Pubitemid 29384344)
12. Schultz-Thater E, Noppen C, Gudat F, Durmuller U, Zajac P, Kocher T, Heberer M, Spagnoli GC,. NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens. Br J Cancer 2000; 83: 204-8. (Pubitemid 30411718)
13. Kocher T, Schultz-Thater E, Gudat F, Schaefer C, Casorati G, Juretic A, Willimann T, Harder F, Heberer M, Spagnoli GC,. Identification and intracellular location of MAGE-3 gene product. Cancer Res 1995; 55: 2236-9.
14. Schmittgen TD, Livak KJ,. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-8. (Pubitemid 351818697)
15. Bolli M, Schultz-Thater E, Zajac P, Guller U, Feder C, Sanguedolce F, Carafa V, Terracciano L, Hudolin T, Spagnoli GC, Tornillo L,. NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study. Int J Cancer 2005; 115: 960-6. (Pubitemid 40791838)
16. Gure AO, Stockert E, Arden KC, Boyer AD, Viars CS, Scanlan MJ, Old LJ, Chen YT,. CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int J Cancer 2000; 85: 726-32. (Pubitemid 30080489)
17. Landry C, Brasseur F, Spagnoli GC, Marbaix E, Boon T, Coulie P, Godelaine D,. Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4. Int J Cancer 2000; 86: 835-41. (Pubitemid 30350199)
18. Schultz-Thater E, Juretic A, Dellabona P, Luscher U, Siegrist W, Harder F, Heberer M, Zuber M, Spagnoli GC,. MAGE-1 gene product is a cytoplasmic protein. Int J Cancer 1994; 59: 435-9. (Pubitemid 24331839)
19. Aubry F, Satie AP, Rioux-Leclercq N, Rajpert-De Meyts E, Spagnoli GC, Chomez P, De Backer O, Jegou B, Samson M,. MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors. Cancer 2001; 92: 2778-85. (Pubitemid 33091914)
20. Satie AP, Rajpert-De Meyts E, Spagnoli GC, Henno S, Olivo L, Jacobsen GK, Rioux-Leclercq N, Jegou B, Samson M,. The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ. Lab Invest 2002; 82: 775-80. (Pubitemid 34633827)
21. Alves PM, Levy N, Bouzourene H, Viatte S, Bricard G, Ayyoub M, Vuilleumier H, Givel JC, Halkic N, Speiser DE, Romero P, Levy F,. Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer. Cancer Immunol Immunother 2007; 56: 839-47. (Pubitemid 46723576)
22. Gure AO, Chua R, Williamson B, Gonen M, Ferrera CA, Gnjatic S, Ritter G, Simpson AJ, Chen YT, Old LJ, Altorki NK,. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Clin Cancer Res 2005; 11: 8055-62. (Pubitemid 41698748)
23. Jacobs JF, Grauer OM, Brasseur F, Hoogerbrugge PM, Wesseling P, Gidding CE, van de Rakt MW, Figdor CG, Coulie PG, de Vries, IJ, Adema GJ,. Selective cancer-germline gene expression in pediatric brain tumors. J Neurooncol 2008; 88: 273-80.
24. Lin J, Lin L, Thomas DG, Greenson JK, Giordano TJ, Robinson GS, Barve RA, Weishaar FA, Taylor JM, Orringer MB, Beer DG,. Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants. Clin Cancer Res 2004; 10: 5708-16. (Pubitemid 39180946)
25. Muller-Richter UD, Dowejko A, Reuther T, Kleinheinz J, Reichert TE, Driemel O,. Analysis of expression profiles of MAGE-A antigens in oral squamous cell carcinoma cell lines. Head Face Med 2009; 5: 10.
26. Peng JR, Chen HS, Mou DC, Cao J, Cong X, Qin LL, Wei L, Leng XS, Wang Y, Chen WF,. Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters. Cancer Lett 2005; 219: 223-32. (Pubitemid 40269487)
27. Sharma P, Shen Y, Wen S, Bajorin DF, Reuter VE, Old LJ, Jungbluth AA,. Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma. Clin Cancer Res 2006; 12: 5442-7. (Pubitemid 44497259)
28. Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA,. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res 2002; 62: 3971-9. (Pubitemid 34791062)
29. Suzuki S, Sasajima K, Sato Y, Watanabe H, Matsutani T, Iida S, Hosone M, Tsukui T, Maeda S, Shimizu K, Tajiri T,. MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer. Br J Cancer 2008; 99: 350-6.
30. Kavalar R, Sarcevic B, Spagnoli GC, Separovic V, Samija M, Terracciano L, Heberer M, Juretic A,. Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study. Virchows Arch 2001; 439: 127-31. (Pubitemid 32758905)
31. Yakirevich E, Sabo E, Lavie O, Mazareb S, Spagnoli GC, Resnick MB,. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms. Clin Cancer Res 2003; 9: 6453-60. (Pubitemid 38031833)
32. Huang LQ, Brasseur F, Serrano A, De Plaen E, van der Bruggen P, Boon T, Van Pel A,. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma. J Immunol 1999; 162: 6849-54. (Pubitemid 29309414)
33. Bracci L, Schumacher R, Provenzano M, Adamina M, Rosenthal R, Groeper C, Zajac P, Iezzi G, Proietti E, Belardelli F, Spagnoli GC,. Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering. J Immunother 2008; 31: 466-74.
34. Chianese-Bullock KA, Pressley J, Garbee C, Hibbitts S, Murphy C, Yamshchikov G, Petroni GR, Bissonette EA, Neese PY, Grosh WW, Merrill P, Fink R, et al. MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma. J Immunol 2005; 174: 3080-6. (Pubitemid 40279730)
35. Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G,. Immunogenic cancer cell death: a key-lock paradigm. Curr Opin Immunol 2008; 20: 504-11.
36. Bergeron A, Picard V, LaRue H, Harel F, Hovington H, Lacombe L, Fradet Y,. High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer. Int J Cancer 2009; 125: 1365-71.
37. Bolli M, Kocher T, Adamina M, Guller U, Dalquen P, Haas P, Mirlacher M, Gambazzi F, Harder F, Heberer M, Sauter G, Spagnoli GC,. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma. Ann Surg 2002; 236: 785-93. (Pubitemid 35403234)
38. Kocher T, Zheng M, Bolli M, Simon R, Forster T, Schultz-Thater E, Remmel E, Noppen C, Schmid U, Ackermann D, Mihatsch MJ, Gasser T, et al. Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study. Int J Cancer 2002; 100: 702-5. (Pubitemid 34832982)
39. Sienel W, Mecklenburg I, Dango S, Ehrhardt P, Kirschbaum A, Passlick B, Pantel K,. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer. Clin Cancer Res 2007; 13: 3840-7. (Pubitemid 47037589)
40. Yang B, O'Herrin SM, Wu J, Reagan-Shaw S, Ma Y, Bhat KM, Gravekamp C, Setaluri V, Peters N, Hoffmann FM, Peng H, Ivanov AV, et al. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res 2007; 67: 9954-62. (Pubitemid 47621245)
41. Yang B, O'Herrin S, Wu J, Reagan-Shaw S, Ma Y, Nihal M, Longley BJ,. Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo. J Invest Dermatol 2007; 127: 267-75. (Pubitemid 46106901)
42. Liu W, Cheng S, Asa SL, Ezzat S,. The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res 2008; 68: 8104-12.
43. Askew EB, Bai S, Hnat AT, Minges JT, Wilson EM,. Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators. J Biol Chem 2009; 284: 34793-808.
44. Karpf AR, Bai S, James SR, Mohler JL, Wilson EM,. Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP. Mol Cancer Res 2009; 7: 523-35.
45. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T,. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 1996; 93: 7149-53. (Pubitemid 26243517)
46. Liu F, Killian JK, Yang M, Walker RL, Hong JA, Zhang M, Davis S, Zhang Y, Hussain M, Xi S, Rao M, Meltzer PA, et al. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 2010; 29: 3650-64.
47. van Doorn R, Gruis NA, Willemze R, van der Velden PA, Tensen CP,. Aberrant DNA methylation in cutaneous malignancies. Semin Oncol 2005; 32: 479-87. (Pubitemid 41396425)
48. Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, Zens MS, Andrew AS, Morris S, Nelson HH, Schned AR, Karagas MR, Marsit CJ,. Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res 2010; 16: 1682-9.
49. Richards KL, Zhang B, Baggerly KA, Colella S, Lang JC, Schuller DE, Krahe R,. Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One 2009; 4: e4941.
50. Ogino S, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Fuchs CS,. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer 2008; 122: 2767-73. (Pubitemid 351631379)